MOORE CAPITAL MANAGEMENT, LP – Regeneron Pharmaceuticals, Inc. Transaction History
MOORE CAPITAL MANAGEMENT, LP portfolio value:
$28.92M
portfolio value
MOORE CAPITAL MANAGEMENT, LP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +76.98% | 18.26K shares | 14.9M | $688.87 | 41.99K |
| Q2 2022 | share | Increase | +37.90% | 6.52K shares | 2.00M | $591.13 | 23.72K |
| Q1 2022 | share | Increase | 0.00% | 17.20K shares | 12.01M | $698.42 | 17.20K |
| Q3 2021 | share | Decrease | -100.00% | -42.64K shares | -23.81M | $605.18 | 0 |
| Q2 2021 | share | Increase | 0.00% | 42.64K shares | 23.81M | $558.54 | 42.64K |
| Q1 2021 | share | Decrease | -100.00% | -22.80K shares | -11.01M | $473.14 | 0 |
| Q4 2020 | share | Increase | 0.00% | 22.80K shares | 11.01M | $483.11 | 22.80K |